MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GOLDSTEIN, M.
Right arrow Articles by JOH, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GOLDSTEIN, M.
Right arrow Articles by JOH, T. H.

Molecular Pharmacology, Vol 3, 396-398, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics

The Effect of Reduced and Oxidized Pteridine on Dopamine-beta-Hydroxylase Activity

MENEK GOLDSTEIN 1 and TONG HYUB JOH 1

1 New York University School of Medicine, Department of Psychiatry and Neurology, Neurochemistry Laboratory, New York, New York 10016

Tetrahydropteridine (DMPH4) reacts with dopamine-beta-hydroxylase anaerobically and forms a reduced enzyme intermediate which aerobically catalyzes the beta-hydroxylation of tyramine-3H. Under aerobic conditions DMPH4, in combination with NADH, is effective in the stimulation of enzymic beta-hydroxylation. Oxidized DMPH4 inhibits the enzymic activity.

Submitted on March 9, 1967






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics